Detailed view for Smp_163640

Basic information

TDR Targets ID: 284832
Schistosoma mansoni, Phosphatidylinositol N-acetylglucosaminyltransferase subunit P
Source Database / ID:  GeneDB

pI: 7.3493 | Length (AA): 140 | MW (Da): 16119 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 2

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF08510   PIG-P

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Structural information

Modbase 3D models:

No model available for this protein in Modbase.

PDB Structures:

No structure availble in the PDB for this protein

Expression

No expression data available for this gene

Orthologs

Ortholog group members (OG5_129128)

Species Accession Gene Product
Arabidopsis thaliana AT1G61280   phosphatidylinositol N-acetylglucosaminyltransferase subunit P
Arabidopsis thaliana AT2G39445   phosphatidylinositol N-acetylglucosaminyltransferase, GPI19/PIG-P subunit
Candida albicans CaO19.3557   similar to S. pombe SPAC22A12.13
Candida albicans CaO19.11041   similar to S. pombe SPAC22A12.13
Cryptosporidium hominis Chro.20095   NPD010
Cryptosporidium parvum cgd2_840   phosphatidylinositol N-acetylglucosaminyltransferase subunit PIG-P, involved in GPI anchor biosynthesis, multitransmembrane doma
Dictyostelium discoideum DDB_G0272006   hypothetical protein
Drosophila melanogaster Dmel_CG14550   CG14550 gene product from transcript CG14550-RA
Entamoeba histolytica EHI_126130   hypothetical protein
Homo sapiens ENSG00000185808   phosphatidylinositol glycan anchor biosynthesis, class P
Leishmania braziliensis LbrM.35.5000   hypothetical protein, conserved
Leishmania donovani LdBPK_364980.1   PIG-P, putative
Leishmania infantum LinJ.36.4980   hypothetical protein, conserved
Leishmania major LmjF.36.4750   hypothetical protein, conserved
Leishmania mexicana LmxM.36.4750   hypothetical protein, conserved
Mus musculus ENSMUSG00000022940   phosphatidylinositol glycan anchor biosynthesis, class P
Plasmodium berghei PBANKA_0836100   phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative
Plasmodium falciparum PF3D7_0935300   phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative
Plasmodium knowlesi PKNH_0734000   phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative
Plasmodium vivax PVX_086955   phosphatidylinositol N-acetylglucosaminyltransferase subunit P, putative
Saccharomyces cerevisiae YDR437W   Gpi19p
Schistosoma japonicum Sjp_0045460   IPR013717,PIG-P,domain-containing
Schistosoma japonicum Sjp_0205230   ko:K03861 phosphatidylinositol glycan, class P, putative
Schistosoma mansoni Smp_163640   Phosphatidylinositol N-acetylglucosaminyltransferase subunit P
Trypanosoma brucei gambiense Tbg972.10.12340   hypothetical protein, conserved
Trypanosoma brucei Tb927.10.10110   PIG-P, putative
Trypanosoma cruzi TcCLB.508307.100   PIG-P, putative
Toxoplasma gondii TGME49_207980   PIG-P protein
Theileria parva TP04_0640   hypothetical protein

Essentiality

Smp_163640 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.10.10110 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.10.10110 Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.10.10110 Trypanosoma brucei significant gain of fitness in procyclic forms alsford
Tb927.10.10110 Trypanosoma brucei no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms alsford
YDR437W Saccharomyces cerevisiae inviable yeastgenome
PBANKA_0836100 Plasmodium berghei Essential plasmo
TGME49_207980 Toxoplasma gondii Probably essential sidik
Show/Hide essentiality data references
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Smp_163640 (Schistosoma mansoni), Phosphatidylinositol N-acetylglucosaminyltransferase subunit P
Title for this comment
Comment